MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 189 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2021. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $245,655 | +4.5% | 7,397 | -0.6% | 0.00% | 0.0% |
Q3 2022 | $235,000 | -2.1% | 7,440 | -5.6% | 0.00% | -50.0% |
Q2 2022 | $240,000 | +18.8% | 7,882 | +1.3% | 0.00% | +100.0% |
Q1 2022 | $202,000 | +57.8% | 7,782 | +23.8% | 0.00% | 0.0% |
Q4 2021 | $128,000 | +2.4% | 6,287 | -3.5% | 0.00% | 0.0% |
Q3 2021 | $125,000 | -19.9% | 6,518 | -7.6% | 0.00% | 0.0% |
Q2 2021 | $156,000 | -10.9% | 7,055 | +5.8% | 0.00% | -50.0% |
Q1 2021 | $175,000 | +400.0% | 6,666 | +260.3% | 0.00% | – |
Q4 2020 | $35,000 | +16.7% | 1,850 | +4.5% | 0.00% | – |
Q3 2020 | $30,000 | -25.0% | 1,770 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $40,000 | -4.8% | 1,770 | -60.0% | 0.00% | 0.0% |
Q3 2019 | $42,000 | -60.4% | 4,430 | -50.6% | 0.00% | -75.0% |
Q2 2019 | $106,000 | -32.9% | 8,960 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $158,000 | +1.3% | 8,960 | 0.0% | 0.01% | -25.0% |
Q4 2018 | $156,000 | +16.4% | 8,960 | 0.0% | 0.01% | +33.3% |
Q3 2018 | $134,000 | – | 8,960 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |